Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
View ORCID ProfileMaxine Lamb, View ORCID ProfileAlexandra G Smith, View ORCID ProfileDaniel Painter, View ORCID ProfileEleanor Kane, View ORCID ProfileTim Bagguley, View ORCID ProfileRobert Newton, View ORCID ProfileDebra Howell, View ORCID ProfileGordon Cook, Ruth de Tute, Andrew Rawstron, Russell Patmore, View ORCID ProfileEve Roman
doi: https://doi.org/10.1101/2020.05.30.20117549
Maxine Lamb
1Department of Health Sciences, University of York, YO10 5DD, UK
Alexandra G Smith
1Department of Health Sciences, University of York, YO10 5DD, UK
Daniel Painter
1Department of Health Sciences, University of York, YO10 5DD, UK
Eleanor Kane
1Department of Health Sciences, University of York, YO10 5DD, UK
Tim Bagguley
1Department of Health Sciences, University of York, YO10 5DD, UK
Robert Newton
1Department of Health Sciences, University of York, YO10 5DD, UK
2Ugandan Virus Research Institute, Entebbe, Uganda
Debra Howell
1Department of Health Sciences, University of York, YO10 5DD, UK
Gordon Cook
3Department of Haematology, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP, UK
Ruth de Tute
4Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP, UK
Andrew Rawstron
4Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, St James’s University Hospital, LS9 7LP, UK
Russell Patmore
5Queens Centre for Oncology and Haematology, Hull University Teaching Hospitals NHS Trust, HU16 5JQ, UK
Eve Roman
1Department of Health Sciences, University of York, YO10 5DD, UK
Data Availability
Ethical approvals and data restrictions mean that data cannot be shared; but collaborative projects can be undertaken. The corresponding author can be contacted for more information.
Posted June 01, 2020.
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
Maxine Lamb, Alexandra G Smith, Daniel Painter, Eleanor Kane, Tim Bagguley, Robert Newton, Debra Howell, Gordon Cook, Ruth de Tute, Andrew Rawstron, Russell Patmore, Eve Roman
medRxiv 2020.05.30.20117549; doi: https://doi.org/10.1101/2020.05.30.20117549
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
Maxine Lamb, Alexandra G Smith, Daniel Painter, Eleanor Kane, Tim Bagguley, Robert Newton, Debra Howell, Gordon Cook, Ruth de Tute, Andrew Rawstron, Russell Patmore, Eve Roman
medRxiv 2020.05.30.20117549; doi: https://doi.org/10.1101/2020.05.30.20117549
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11631)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3636)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)